基因逆转肿瘤多药耐药的研究进展

被引：4

作者：

董改霞

洪行球

黄燕芬

机构：

[1] 浙江中医药大学生命科学学院

来源：

现代生物医学进展 | 2008年 / 8卷 / 12期

关键词：

肿瘤; 多药耐药; 基因;

D O I：

10.13241/j.cnki.pmb.2008.12.090

中图分类号：

R730.5 [肿瘤治疗学];

学科分类号：

摘要：

化疗在恶性肿瘤的综合治疗中占有非常重要的地位,而耐药性是严重影响肿瘤病人化疗效果及生存的主要原因之一,其中多药耐药(multi-drug resistance,MDR)最具临床意义。多药耐药是指肿瘤细胞对某一化疗药物产生耐药性后,对其他化学结构及机理不同的化疗药物也产生交叉耐药性。研究表明MDR是一个多阶段发展、多因素参与的复杂事件。逆转肿瘤多药耐药是目前肿瘤化疗的研究热点之一。近年随着基础科学研究的不断深入,基因逆转肿瘤多药耐药的研究已从分子水平上,定点、多位点阻断多药耐药基因的表达,已取得一些显著的进展。本文对肿瘤多药耐药机制以及逆转肿瘤多药耐药性的相关基因做一简要综述。

引用

页码：2367 / 2369

页数：3

共 18 条

[1]

The judgment of the prognosis of cancer on immune markers Group. Yu Ying-hao. Diagnostic Pathology . 2001

[2] Blocking oncogenes in malignant cells by RNA interference - New hope for a highly specific cancer treatment? [J].

Borkhardt, A .

CANCER CELL, 2002, 2 (03) :167-168

[3]

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance[J] . T. Litman,T. E. Druley,W. D. Stein,S. E. Bates. &nbspCellular and Molecular Life Sciences . 2001 (7)

[4]

Apoptosis induction by a novel antiprostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Joshi B,Li L,Taffe BG,et al. Cancer Research . 1999

[5]

Rate-limiting step preceding cytochrome c release in cells primed for Fas-mediated apoptosis revealed by analysis of cellular mosaicism of respiratory changes. Hajek,P,Villani,G,Attardi,G. Journal of Biological Chemistry . 2001

[6]

Molecular mechanisms of spoptosis and Chemosensitivity to platinum end paclitaxel in ovarian cancer biological data and Clinical implications. Oadducci A,Cosio S,MUrace S,et al. Eur Gynsecol On- col . 2002

[7]

Research progress mitochondrial genome and tumor drug resistance. Huang Wei,ZhangYao-zhen. . 2001

[8]

From MDR to MXR:New understanding of multidrug resistance sys- tems,their properties and clinical significance. Litman T,Druley TE,Stein WD,et al. Cellular and Molecular Life Sciences . 2001

[9]

siRNA reversed multi-drug resistan of K562/A02 cell. Peng Zhi,Xiao Zhi-jian,Wang Yi,et al. Chinese Journal of Hematology . 2004

[10]

Progress of Multi-drug resistant tumor mecha- nism. Gui Xian,Liu Hui-min. Shanghai Medical Journal . 2006

← 1 2 →